GE HealthCare Technologies Inc. $GEHC Stock Holdings Increased by New York Life Investment Management LLC

New York Life Investment Management LLC boosted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 62,532 shares of the company’s stock after buying an additional 1,193 shares during the quarter. New York Life Investment Management LLC’s holdings in GE HealthCare Technologies were worth $4,632,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. boosted its stake in GE HealthCare Technologies by 49.9% in the first quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock valued at $414,894,000 after acquiring an additional 1,711,963 shares during the period. Nuveen LLC acquired a new position in GE HealthCare Technologies in the first quarter valued at approximately $77,058,000. Eminence Capital LP boosted its stake in GE HealthCare Technologies by 38.7% in the first quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock valued at $146,822,000 after acquiring an additional 507,101 shares during the period. Homestead Advisers Corp boosted its stake in GE HealthCare Technologies by 92.7% in the first quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock valued at $79,790,000 after acquiring an additional 475,500 shares during the period. Finally, Canada Pension Plan Investment Board boosted its stake in GE HealthCare Technologies by 15.2% in the first quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock valued at $251,121,000 after acquiring an additional 409,636 shares during the period. 82.06% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the company. Barclays assumed coverage on GE HealthCare Technologies in a research note on Monday, October 13th. They issued an “equal weight” rating and a $86.00 target price for the company. Wall Street Zen downgraded GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. BTIG Research set a $87.00 target price on GE HealthCare Technologies in a research note on Wednesday. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Tuesday, October 14th. Finally, Morgan Stanley set a $74.00 price objective on GE HealthCare Technologies in a research report on Thursday, September 18th. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $85.00.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC opened at $77.38 on Thursday. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. The stock has a 50 day simple moving average of $75.06 and a 200-day simple moving average of $72.90. The company has a market cap of $35.33 billion, a PE ratio of 15.86, a P/E/G ratio of 3.03 and a beta of 1.13. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $5.07 billion. During the same period in the previous year, the firm posted $1.14 earnings per share. The business’s revenue was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 2.87%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.